Hot Products
| Catalog No. | Information |
| CFN92067 | Anagyrine Anagyrine, is the responsible teratogen from teratogenic lupins, can produce congenital deformities in calves typical of crooked calf disease; it also can induce red cell aplasia, vascular anomaly, and skeletal dysplasia.(-)-Anagyrine and (-)--Methylcytisine have nematicidal activities against Pine Wood Nematodes. |
| CFN95210 | Andrographidine A Reference standards. |
| CFN97852 | Andrographidine C Standard reference |
| CFN97851 | Andrographidine E Andrographidine E is a natural product from Andrographis paniculata. |
| CFN98923 | Andrographolide Andrographolide is an antiinflammatory, antiviral, anti-cancer , hepatoprotective, antithrombotic, hypotensive and antiatherosclerotic drug, it can cure hyperpigmentation disorders. Andrographolide protects against chemical-induced oxidative damage by up-regulating the gene transcription and activity of antioxidant enzymes in various tissues.Andrographolide has potential as a leading compound in the prevention or treatment of obesity and insulin resistance, can ameliorate lipid metabolism and improve glucose use in mice with HFD-induced obesity. |
| CFN93252 | Androsin Androsin has antiasthmatic effects , it can prevent allergen- and platelet-activating factor (PAF)-induced bronchial obstruction (10 mg/kg orally; 0.5 mg inhalative). |
| CFN93200 | Anemarrhenasaponin I Anemarrhenasaponin I shows remarkable inhibiting effect on platelet aggregation. |
| CFN99532 | Anemarsaponin B Anemarsaponin B can inhibit PAF-induced rabbit platelet aggregation in vitro. Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway. |
| CFN90778 | Anemarsaponin BIII Reference standards. |
| CFN99533 | Anemarsaponin E Anemarsaponin E is a nartural product from salt Anemarrhenae Rhizoma. |
